Age, Biography and Wiki

Andreas Bernkop-Schnürch was born on 6 December, 1965 in Klagenfurt, Austria, is an Austrian university teacher (born 1965). Discover Andreas Bernkop-Schnürch's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 58 years old?

Popular As N/A
Occupation N/A
Age 58 years old
Zodiac Sign Sagittarius
Born 6 December 1965
Birthday 6 December
Birthplace Klagenfurt, Austria
Nationality Austria

We recommend you to check the complete list of Famous People born on 6 December. He is a member of famous teacher with the age 58 years old group.

Andreas Bernkop-Schnürch Height, Weight & Measurements

At 58 years old, Andreas Bernkop-Schnürch height not available right now. We will update Andreas Bernkop-Schnürch's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Andreas Bernkop-Schnürch Net Worth

His net worth has been growing significantly in 2023-2024. So, how much is Andreas Bernkop-Schnürch worth at the age of 58 years old? Andreas Bernkop-Schnürch’s income source is mostly from being a successful teacher. He is from Austria. We have estimated Andreas Bernkop-Schnürch's net worth, money, salary, income, and assets.

Net Worth in 2024 $1 Million - $5 Million
Salary in 2024 Under Review
Net Worth in 2023 Pending
Salary in 2023 Under Review
House Not Available
Cars Not Available
Source of Income teacher

Andreas Bernkop-Schnürch Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

1965

Andreas Bernkop-Schnürch (born in Klagenfurt, December 6, 1965) is an Austrian scientist and entrepreneur.

He is Head of the Department of Pharmaceutical Technology in the Institute of Pharmacy at the University of Innsbruck.

His research centers on the areas of drug delivery, dosage forms, controlled release, bionanotechnology, polymer engineering and tissue engineering.

1994

He was educated in pharmacy and in microbiology and genetics at the University of Vienna, finishing his doctorate in 1994.

From 1994 to 1999, he was a postdoctoral fellow at the Institute of Pharmacy, University of Vienna.

1999

In 1999, he applied to qualify as a professor by receiving the "venia docendi" in pharmaceutical technology.

2000

He is the inventor of several technologies, such as thiolated polymers, for which he coined the name thiomers in 2000, and phosphatase triggered charge-converting nanoparticles for mucosal drug delivery.

2001

He introduced thiolated polysaccharides as new biopolymers for tissue engineering at the 4th Central European Symposium on Pharmaceutical Technology in Vienna 2001, resulting in numerous products containing thiomers such as thiolated chitosans or thiolated hyaluronic acid.

The thiomer-technology also contributed to the development of thiolated nanoparticles that are used as carriers for drug delivery, as diagnostics, and as biosensorics.

2003

Since 2003, he has held the chair in pharmaceutical technology at the University of Innsbruck, heading the Department of Pharmaceutical Technology.

2006

From 2006 to 2013, he served as dean of the Faculty of Chemistry and Pharmacy.

In 2022, he was a visiting professor at the University of Bari Aldo Moro.

He has been a member of the senate of the University of Innsbruck since 2021.

Andreas Bernkop-Schnürch is known for his research on drug delivery systems, multifunctional polymers, and tissue engineering.

He invented and pioneered thiolated polymers – thiomers – as a new generation of bio- and mucoadhesive polymers forming disulfide bonds with cysteine-rich subdomains of endogenous proteins, such as mucus glycoproteins or keratins.

Various medicines based on thiomers have already successfully passed clinical trials and first products for purposes such as treatment of dry eye syndrome have already reached the global pharmaceutical market.

2014

He has been on the scientific advisory board of the Nicotine Science Center of Denmark since 2014.

2015

Likely the smallest thiolated nanocarriers for drug delivery are thiolated cyclodextrins, which he introduced in 2015,

providing in particular a prolonged residence time on mucosal membranes, exhibiting permeation enhancing as well as efflux pump inhibiting properties, and improving cellular uptake.

Furthermore, Andreas Bernkop-Schnürch pioneered charge-converting nanoparticles for mucosal drug delivery utilizing the membrane bound enzyme Alkaline phosphatase to trigger a shift in zeta potential from negative to positive directly at the epithelium.

Cationic nanoparticles are more efficiently taken up by epithelial cells than anionic ones.

However, they do not reach epithelial cells, as they are immobilized via ionic interactions in mucus, displaying an anionic charge because of sialic acid substructures.

Charge-converting nanoparticles address this so-called ‘polycation dilemma’ by converting their surface charge to positive at the cellular membrane.

Moreover, Andreas Bernkop-Schnürch contributed basic knowledge to the field of self-emulsifying drug delivery systems (SEDDS) for mucosal delivery of macromolecular drugs.

Andreas Bernkop-Schnürch has been awarded more than 20 national and international awards.

These include:

Andreas Bernkop-Schnürch is author of over 500 research articles and reviews, as well as editor and (co-)author of several books.

2016

From 2016 to 2018, he served as a member of the Scientific Committee of the Innovative Medicines Initiative (IMI) of the European Union in Brussels, giving advice on scientific priorities to be included in the Strategic Research Agenda for Horizon 2020.

He is a member of the editorial board of numerous pharmaceutical journals, including the International Journal of Pharmaceutics, the Journal of Drug Delivery Science and Technology, Scientia Pharmaceutica, Drug Development and Industrial Pharmacy, and the European Journal of Pharmaceutics and Biopharmaceutis.

Andreas Bernkop-Schnürch is the founder of Thiomatrix Forschungs- und Beratungs GmbH, Mucobiomer Biotechnologische Forschungs- und Entwicklungs GmbH (now part of the Croma-Pharma GmbH) and Green River Polymers Forschungs und Entwicklungs GmbH.

He has been listed as a Highly Cited Researcher of the Institute of Scientific Information since 2022.

Andreas Bernkop-Schnürch comes from an Austrian apothecary family.